Tharimmune, Inc. Quarterly Debt-to-equity in % from Q3 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Tharimmune, Inc. quarterly Debt-to-equity history and growth rate from Q3 2022 to Q3 2024.
Tharimmune, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 28.8 %, a 30.4% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	28.8	-12.5	-30.4%	Sep 30, 2024
Q2 2024	26.9	-0.03	-0.11%	Jun 30, 2024
Q1 2024	31.4	+12.2	+63.7%	Mar 31, 2024
Q4 2023	36.6	+21	+134%	Dec 31, 2023
Q3 2023	41.3	-0.73	-1.74%	Sep 30, 2023
Q2 2023	26.9			Jun 30, 2023
Q1 2023	19.2			Mar 31, 2023
Q4 2022	15.6			Dec 31, 2022
Q3 2022	42			Sep 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.